HealthX Connect Osaka 2026

1 Jul 2026 | Osaka, Japan

Register
Register
Register

Jiksak Bioengineering, Inc.

Company (SME/startup) / 中小企業・スタートアップ

www.jiksak.co.jp/Kawasaki, Japan
7 profile visits

About

At Jiksak—where innovation meets neuron drug delivery and nerve repair. We're a biotech company dedicated to groundbreaking therapies for neurodegenerative disorders and nerve repair. Our technologies include:

·       Drug-Linked Carrier (DLC): An advanced drug delivery system utilizing motor neuron axons to bypass the Blood-Brain Barrier (BBB) and Blood-Spinal Cord Barrier (BSCB) for drug delivery into the CNS.

Publication: Yee, KKL et al. Molecular Therapy: Methods & Clinical Development (Vol. 33, Issue 2) ; ”Harnessing synaptic vesicle release and recycling with antibody shuttle for targeted delivery of therapeutics to neurons” https://www.sciencedirect.com/science/article/pii/S2329050125000713

Business Type / 業種

R&D / 研究開発

Disease Area/疾患領域

Neurology & Psychiatry/中枢神経、精神疾患Rare diseases / 希少疾患Others/その他

Business Domain / 分野

Pharmaceuticals / 医薬品

Technologies / 技術

Drug delivery system(DDS) / ドラッグデリバリーシステム

Additional Information

Requested business parter / ご希望のビジネスパートナー 

Pharmaceuticals / 医薬品Neurology & Psychiatry/中枢神経、精神疾患Rare diseases / 希少疾患

Representatives

Business development

Jiksak Bioengineering, Inc.

Business development licensing

Jiksak Bioengineering, Inc.